TECHNOLOGY - April 17, 1993
From Times Staff and Wire Reports
Genentech Earnings Surge: Genentech Inc. said in San Francisco its earnings more than tripled in the first quarter on strong royalty payments and sales of its Protropin hormone and Activase heart drug. Net income rose to $14.3 million, or 12 cents a share, from $3.5 million, or 3 cents, a year earlier. The mean estimate of analysts surveyed by Zacks Investment Research was for earnings of 5 cents.
